BSE Live
Prev. Close
Open Price
Bid Price (Qty.)
()
Offer Price (Qty.)
()
NSE Live
Apr 17, 15:56Prev. Close
25.57
Open Price
26.49
Bid Price (Qty.)
26.37 (1207)
Offer Price (Qty.)
0.00 (0)
| Balance Sheet of Balaxi Pharmaceuticals (in Rs. Cr.) | Mar 15 | Mar 14 | Mar 13 | Mar 12 | |
| 12 mths | 12 mths | 12 mths | 12 mths | ||
| EQUITIES AND LIABILITIES | |||||
| SHAREHOLDER'S FUNDS | |||||
| Equity Share Capital | 3.04 | 0.70 | 0.70 | 0.70 | |
| Total Share Capital | 3.04 | 0.70 | 0.70 | 0.70 | |
| Reserves and Surplus | 0.02 | 0.03 | 0.01 | 0.04 | |
| Total Reserves and Surplus | 0.18 | 0.08 | 0.05 | 0.08 | |
| Total Shareholders Funds | 3.22 | 0.78 | 0.75 | 0.78 | |
| NON-CURRENT LIABILITIES | |||||
| Long Term Borrowings | 0.00 | 0.00 | 0.00 | 0.22 | |
| Deferred Tax Liabilities [Net] | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other Long Term Liabilities | 0.00 | 0.00 | 0.00 | 0.00 | |
| Long Term Provisions | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Non-Current Liabilities | 0.00 | 0.00 | 0.00 | 0.22 | |
| CURRENT LIABILITIES | |||||
| Short Term Borrowings | 0.00 | 0.18 | 0.00 | 0.00 | |
| Trade Payables | 0.13 | 0.00 | 0.00 | 0.00 | |
| Other Current Liabilities | 0.03 | 0.02 | 0.31 | 0.01 | |
| Short Term Provisions | 0.30 | 0.22 | 0.17 | 0.17 | |
| Total Current Liabilities | 0.46 | 0.42 | 0.49 | 0.18 | |
| Total Capital And Liabilities | 3.68 | 1.20 | 1.24 | 1.18 | |
| ASSETS | |||||
| NON-CURRENT ASSETS | |||||
| Tangible Assets | 0.00 | 0.00 | 0.00 | 0.00 | |
| Intangible Assets | 0.00 | 0.00 | 0.00 | 0.00 | |
| Capital Work-In-Progress | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other Assets | 0.00 | 0.00 | 0.00 | 0.00 | |
| Fixed Assets | 0.00 | 0.00 | 0.00 | 0.00 | |
| Non-Current Investments | 3.42 | 0.18 | 0.47 | 0.33 | |
| Deferred Tax Assets [Net] | 0.00 | 0.00 | 0.00 | 0.00 | |
| Long Term Loans And Advances | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other Non-Current Assets | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Non-Current Assets | 3.42 | 0.18 | 0.47 | 0.33 | |
| CURRENT ASSETS | |||||
| Current Investments | 0.00 | 0.01 | 0.00 | 0.16 | |
| Inventories | 0.00 | 0.00 | 0.00 | 0.00 | |
| Trade Receivables | 0.01 | 0.29 | 0.00 | 0.00 | |
| Cash And Cash Equivalents | 0.02 | 0.55 | 0.54 | 0.55 | |
| Short Term Loans And Advances | 0.00 | 0.00 | 0.22 | 0.14 | |
| OtherCurrentAssets | 0.23 | 0.18 | 0.00 | 0.00 | |
| Total Current Assets | 0.26 | 1.03 | 0.77 | 0.85 | |
| Total Assets | 3.68 | 1.20 | 1.24 | 1.18 | |
| OTHER ADDITIONAL INFORMATION | |||||
| CONTINGENT LIABILITIES, COMMITMENTS | |||||
| Contingent Liabilities | 0.00 | 0.00 | 0.00 | 0.00 | |
| CIF VALUE OF IMPORTS | |||||
| Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | |
| Stores, Spares And Loose Tools | 0.00 | 0.00 | 0.00 | 0.00 | |
| Trade/Other Goods | 0.00 | 0.00 | 0.00 | 0.00 | |
| Capital Goods | 0.00 | 0.00 | 0.00 | 0.00 | |
| EXPENDITURE IN FOREIGN EXCHANGE | |||||
| Expenditure In Foreign Currency | 0.00 | 0.00 | 0.00 | 0.00 | |
| REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS | |||||
| Dividend Remittance In Foreign Currency | -- | -- | -- | -- | |
| EARNINGS IN FOREIGN EXCHANGE | |||||
| FOB Value Of Goods | -- | -- | -- | -- | |
| Other Earnings | -- | -- | -- | -- | |
| BONUS DETAILS | |||||
| Bonus Equity Share Capital | 0.65 | 0.65 | 0.65 | 0.65 | |
| NON-CURRENT INVESTMENTS | |||||
| Non-Current Investments Quoted Market Value | -- | -- | -- | -- | |
| Non-Current Investments Unquoted Book Value | 3.41 | 0.14 | 0.46 | 0.21 | |
| CURRENT INVESTMENTS | |||||
| Current Investments Quoted Market Value | -- | -- | -- | -- | |
| Current Investments Unquoted Book Value | 0.00 | 0.00 | 0.00 | 0.16 |
29.01.2026
Balaxi Pharma Consolidated December 2025 Net Sales at Rs 72.54 crore, down 1.02% Y-o-Y
29.01.2026
Balaxi Pharma Standalone December 2025 Net Sales at Rs 24.59 crore, up 120.41% Y-o-Y
19.11.2025
Balaxi Pharma Consolidated September 2025 Net Sales at Rs 56.18 crore, down 27.41% Y-o-Y
18.11.2025
Balaxi Pharma Standalone September 2025 Net Sales at Rs 19.31 crore, down 8.72% Y-o-Y
29.01.2026
Balaxi Pharma Consolidated December 2025 Net Sales at Rs 72.54 crore, down 1.02% Y-o-Y
29.01.2026
Balaxi Pharma Standalone December 2025 Net Sales at Rs 24.59 crore, up 120.41% Y-o-Y
19.11.2025
Balaxi Pharma Consolidated September 2025 Net Sales at Rs 56.18 crore, down 27.41% Y-o-Y
18.11.2025
Balaxi Pharma Standalone September 2025 Net Sales at Rs 19.31 crore, down 8.72% Y-o-Y
16.04.2026
14.06.2024
Gautam Adani raises stake in Adani Enterprises, buys more from open market
11.06.2024
Adani Enterprises' defence arm partners EDGE group to tap global military market; stock up 1%
31.05.2024
02.05.2024
09.04.2024
02.11.2023
03.08.2023
Adani Enterprises Q1 results: Net profit up 44% at Rs 674 crore, revenue down 38%
21.02.2019
Shaily Engineering Plastics: A disappointing Q3, but don’t overlook its long-term prospects
31.01.2019
Q3 earnings make these two stocks worthy additions to your portfolio
17.08.2018
Shaily Engineering Plastics: Home furnishing products crucial to success
17.05.2018
Shaily Engineering Plastics: Corrections could provide good entry opportunities